[1]
2022. RESULTS OF THE STUDY OF RESISTANCE TO CLARITHROMYCIN IN PATIENTS WITH HELICOBACTER PYLORI-ASSOCIATED GASTRIC DISEASES IN UZBEKISTAN. Journal of Pharmaceutical Negative Results. (Oct. 2022), 3252–3257. DOI:https://doi.org/10.47750/pnr.2022.13.S06.439.